Ratings by Morgan Stanley (Kallum Titchmarsh)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/17/2026 | IQVIA Holdings | IQV | Downgrade | Equalweight (Overweight) |
179.17 (205.97) |
14.96% | Details | |
| 6/17/2026 | Charles River Labs | CRL | Upgrade | Overweight (Equalweight) |
184.79 (231.43) |
25.24% | Details | |
| 5/12/2026 | Personalis | PSNL | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/12/2026 | Mettler-Toledo | MTD | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/12/2026 | Cytek Biosciences Inc | CTKB | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/12/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/12/2026 | 10X Genomics | TXG | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/7/2026 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 4/27/2026 | West Pharmaceutical | WST | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/27/2026 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 4/22/2026 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 3/31/2026 | MiniMed Group | MMED | New Coverage | Overweight (N/A) |
14.35 (15.29) |
6.55% | Details | |
| 3/6/2026 | Stevanato Group S.p.A. | STVN | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/5/2026 | Veracyte, Inc | VCYT | Maintain | Underweight (N/A) |
|
Details | ||
| 3/4/2026 | Personalis | PSNL | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/3/2026 | Tempus AI Inc | TEM | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2026 | Natera | NTRA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/2/2026 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | GRAIL, Inc. | GRAL | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/23/2026 | Waters Corp. | WAT | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/19/2026 | Inspire Medical Systems | INSP | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/11/2026 | IQVIA Holdings | IQV | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2026 | Mettler-Toledo | MTD | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/2/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2025 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2025 | Alphatec Holdings | ATEC | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/2/2025 | Inspire Medical Systems | INSP | Downgrade | Equalweight (Overweight) |
126.34 (49.45) |
-60.86% | Details | |
| 12/2/2025 | Cytek Biosciences Inc | CTKB | New Coverage | Equalweight (N/A) |
5.65 (4.62) |
-18.23% | Details | |
| 12/2/2025 | Agilent | A | New Coverage | Overweight (N/A) |
153.50 (130.60) |
-14.92% | Details | |
| 12/2/2025 | Stevanato Group S.p.A. | STVN | New Coverage | Equalweight (N/A) |
23.36 (19.28) |
-17.47% | Details | |
| 12/2/2025 | 10X Genomics | TXG | New Coverage | Equalweight (N/A) |
18.81 (40.00) |
112.65% | Details | |
| 12/2/2025 | Waters Corp. | WAT | New Coverage | Equalweight (N/A) |
403.42 (378.89) |
-6.08% | Details | |
| 12/2/2025 | Veracyte, Inc | VCYT | New Coverage | Equalweight (N/A) |
47.34 (58.00) |
22.52% | Details | |
| 12/2/2025 | Personalis | PSNL | New Coverage | Equalweight (N/A) |
10.73 (14.34) |
33.64% | Details | |
| 12/2/2025 | GRAIL, Inc. | GRAL | New Coverage | Equalweight (N/A) |
110.39 (68.95) |
-37.54% | Details | |
| 12/2/2025 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Equalweight (N/A) |
19.66 (21.50) |
9.36% | Details | |
| 12/2/2025 | Tempus AI Inc | TEM | New Coverage | Overweight (N/A) |
77.93 (60.70) |
-22.11% | Details | |
| 12/2/2025 | Natera | NTRA | New Coverage | Overweight (N/A) |
238.81 (283.80) |
18.84% | Details | |
| 12/2/2025 | Guardant Health | GH | New Coverage | Overweight (N/A) |
108.42 (168.82) |
55.71% | Details | |
| 12/2/2025 | Thermo Fisher Scientific | TMO | New Coverage | Overweight (N/A) |
590.83 (517.60) |
-12.39% | Details | |
| 12/2/2025 | Charles River Labs | CRL | New Coverage | Equalweight (N/A) |
178.14 (184.79) |
3.73% | Details | |
| 12/2/2025 | IQVIA Holdings | IQV | New Coverage | Overweight (N/A) |
230.01 (179.17) |
-22.1% | Details | |
| 12/2/2025 | Danaher | DHR | New Coverage | Overweight (N/A) |
226.78 (193.62) |
-14.62% | Details | |
| 12/2/2025 | West Pharmaceutical | WST | New Coverage | Equalweight (N/A) |
277.25 (357.64) |
29% | Details | |
| 12/2/2025 | Mettler-Toledo | MTD | New Coverage | Equalweight (N/A) |
1476.72 (1295.56) |
-12.27% | Details | |
| 11/10/2025 | Alphatec Holdings | ATEC | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/14/2025 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2025 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/31/2025 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2025 | Inspire Medical Systems | INSP | Maintain | Overweight (N/A) |
|
Details | ||
| 7/15/2025 | Globus Medical | GMED | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2025 | Alphatec Holdings | ATEC | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/19/2025 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/11/2025 | Inspire Medical Systems | INSP | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2024 | SI-BONE Inc. | SIBN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2024 | Alphatec Holdings | ATEC | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/2/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/2/2024 | Nevro Corp | NVRO | Downgrade | Underweight (Equalweight) |
4.60 (5.84) |
26.96% | Details | |
| 12/2/2024 | Globus Medical | GMED | Upgrade | Overweight (Equalweight) |
85.61 (80.50) |
-5.97% | Details | |
| 12/2/2024 | Embecta | EMBC | Upgrade | Overweight (Underweight) |
20.83 (3.28) |
-84.25% | Details | |
| 11/5/2024 | Inspire Medical Systems | INSP | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2024 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/31/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2024 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/15/2024 | Inspire Medical Systems | INSP | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/3/2024 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 4/9/2024 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/19/2024 | Inspire Medical Systems | INSP | New Coverage | Overweight (N/A) |
199.23 (49.45) |
-75.18% | Details | |
| 3/8/2024 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 12/4/2023 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/8/2023 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/3/2023 | Penumbra | PEN | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/13/2023 | Sight Sciences Inc. | SGHT | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/6/2023 | Penumbra | PEN | New Coverage | Equalweight (N/A) |
262.10 (318.23) |
21.42% | Details |
